N | Unadjusted OR (95% CI) | P value | |
Week 4: | |||
Treatment | |||
Control | 18 | Ref. | |
Early second IVIg | 18 | 0.74 (0.21 to 2.64) | 0.64 |
Control | 16 | Ref. | |
Late second IVIg | 16 | 1.03 (0.26 to 4.13) | 0.97 |
Week 26: | |||
Treatment | |||
Control | 16 | Ref. | |
Early second IVIg | 16 | 1.26 (0.35 to 4.60) | 0.73 |
Control | 12 | Ref. | |
Late second IVIg | 11 | 0.42 (0.09 to 1.90) | 0.26 |
IVIg, intravenous immunoglobulin.